Media

Article in newspaper 'De Gelderlander' about initiation of clinical Phase 1/2 study with T-Guard®, May 20th, 2025 (in Dutch):

READ THE ARTICLE

Article in NVLE Magazine by Dr. Madelon Vonk about T-Guard, April 2025 (in Dutch):

READ THE ARTICLE

News item on site Radboud university medical center:

Funding for research into drug against systemic sclerosis
Radboudumc Holding one of several investors in startup Philikos

READ THE ARTICLE
READ THE ARTICLE IN DUTCH

Publication Annals Rheumatic Diseases on Systemic Sclerosis:

CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion

READ THE ARTICLE

YouTube film ARD: